Podcast appearances and mentions of Mark A Lewis

In this episode, hosts Shikha Jain, MD, Douglas H. Jones, MD, Amy Comander, MD, Dagny Zhu, MD, Don Dizon, MD, and Mark A. Lewis, MD, discuss the new social media platform, Threads and how physicians can use it for their practice. •    Welcome to another exciting episode of Oncology Overdrive :57 •    The topic 1:10 •    How many have created a profile on Threads? Why or why not? 2:59 •    Dr. Jain has a Thread profile but is unsure how to get more engagement 3:20 •    Dr. Lewis has convinced coworkers to use social media but has not used Threads yet 4:54 •    Dr. Dizon has a Thread profile but notes that leaving other platforms is leaving those communities and starting all over on a new platform 6:25 •    Giving Threads more time to pick up followers and engagement 11:18  •    Dr. Zhu has a Thread profile and found it easy to create but engagement is not the same as other platforms 12:17 •    Tips and tricks to sharing content on socials, especially Threads 14:33  •    Trouble with other social media platforms 17:55 •    Tips and tricks to building a community on a social media 20:20 •    The power of social media platforms and engagement in established communities 22:30 •    Fighting misinformation 25:13 •    Platforms versus audience 27:15 •    How would you like to see Threads change as a platform? 31:21 •    What is the power of TikTok in terms of getting movement among communities? 33:31 •    How do you create a profile on Threads? 40:30 •    Level of engagement: Twitter vs. Threads 43:31 •    The overwhelming number of platforms 52:29 •    What is the best platform for physicians to use? 53:41 •    Sharable content to post across other platforms 55:34 •    Final thoughts 58:09 •    Thanks for listening 1:02:13 Douglas H. Jones, MD, is the cofounder of Global Food Therapy, cofounder and president of Food Allergy Support Team and director of Rocky Mountain Allergy at Tanner Clinic. You can follow him on Threads @drdouglasjones. Amy Comander, MD, DipABLM, is director of breast oncology and survivorship at the Massachusetts General Hospital Cancer Center in Waltham and at Newton-Wellesley, and medical director of the Massachusetts General Hospital Cancer Center in Waltham. She is director of the Lifestyle Medicine Program at the Massachusetts General Hospital Cancer Center. She is also an instructor in medicine at Harvard Medical School. You can follow her on Threads @dramycomander. Shika Jain, MD, FACP, is an associate professor of medicine with tenure in the division of hematology, oncology and cell therapy at the University of Illinois Cancer Center in Chicago. She is the director of communication strategies in medicine and associate director of oncology communication and digital innovation. She also is consulting editor for Healio Women in Oncology, as well as host of Healio's Oncology Overdrive podcast. You can follow her on Threads @shikajainmd. Dagny Zhu, MD, is a cornea, cataract, and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. You can follow her on Threads @dzeyemd. Don S. Dizon, MD, FACP, FASCO, is head of community outreach and engagement at the Cancer Center at Brown University and head of the breast and pelvic malignancies program at Lifespan Cancer Institute. You can follow him on Twitter (X) and TikTok @drdonsdizon. Mark A. Lewis, MD, is the director of gastrointestinal oncology at Intermountain Healthcare in Murray, Utah, and a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. You can follow him on Twitter (X) @marklewismd. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Disclosures: The moderators and panelists report no relevant financial disclosures.

Multiple Endocrine Neoplasia is a difficult diagnosis for patients, families, and clinicians. The vast array of symptoms, affected organs, and complex genetics often mean that it can take years (if not longer) for it to be diagnosed. In addition, the impact for the patient is significant as it is a familial disease that is autosomal dominant with very high penetrance. These syndromes were only identified around the 1960s. However, clinical suspicions were unable to be confirmed as the molecular/genetic techniques only in its infancy. It is a rare condition but one that is critical to recognise early to ensure we provide the best care and management for patients and their families. Special Guest Mark A. Lewis, MD, is director of gastrointestinal oncology at Intermountain Healthcare in Utah. Specializing in cancers of the gastrointestinal tract and accessory organs, his interests focus on hereditary cancer syndromes and young-onset cancers, shared decision-making, and patient-physician communication. The death of his father not only took a huge emotional toll on Lewis, but also piqued his intellectual curiosity. Lewis' paternal uncle and grandfather both died of rare cancer types and then Lewis was diagnosed with a suspicious symptom himself – hypercalcemia, or high levels of calcium – something his father had also experienced. As Lewis completed his medical training and established his current position as a haematologist/oncologist at Intermountain Healthcare in Utah, his PNETs were serially monitored. After the dominant PNET changed, crossing a threshold of concern, he had surgery and has documented the experience. Lewis had another special person in mind though and says, “I wanted my son, who has inherited MEN1 from me and may one day require pancreatic surgery himself, to have a record of my own operation.” Quote: “Pancreatic cancer need not be viewed as a death sentence.” REFERENCE pancan.org/news/quest-understand-fathers-illness-young-doctor-discovers/ See omnystudio.com/listener for privacy information.

Mark A. Lewis, MD, is a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. In this episode, he talks about his path to becoming a GI oncologist and living with multiple endocrine neoplasia type 1. Intro :14 About Lewis :27 The interview 1:14 How did you become a GI oncologist? What was your journey to get to where you are now? 1:57 Did you make a conscious decision that you were going to start sharing what was going on with you? 8:15 How Lewis’s social media engagement made an impact on Jain and the humanization of oncologists 20:52 The risk benefits of masks and vaccines in the age of COVID-19 27:27 The benefits and drawbacks of telehealth in the age of COVID-19 33:29 How have Lewis and his wife navigated Lewis’s diagnosis and the pandemic? 40:01 Lewis’s one pearl of wisdom 44:29 Where to find Lewis 46:51   Mark A. Lewis, MD, is the director of gastrointestinal oncology at Intermountain Healthcare in Murray, Utah, and a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. A published researcher, Lewis has also served as a reviewer for multiple peer-reviewed journals. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com.  Lewis can be reached on Twitter @marklewismd. Follow us on Twitter @HemOncToday @ShikhaJainMD. Disclosures: Jain reports she is a paid freelance writer for Lippincott. Lewis reports no relevant financial disclosures.

Dr. Mark A. Lewis, MD, Director of GI Oncology at Intermountain Healthcare in Salt Lake City, shares his perspective as both an oncologist and a pancreatic cancer patient in this unique and fascinating episode.

Coverage of COVID-19 and how it affects the pancreatic cancer community continues with a conversation with Dr. Mark A. Lewis, MD, Director of GI cancer at Intemrountain Healthcare in Salt Lake City, Utah.

A research expedition to the Arctic discovers that a melting polar ice cap has released a deadly prehistoric parasite. Director: Mark A. Lewis Writers: Mark A. Lewis, Michael Lewis Stars: Val Kilmer, Martha MacIsaac, Kyle Schmid See more » Awards: 1 win & 13 nominations. See more » --- Send in a voice message: https://anchor.fm/gruesome-hertzogg/message Support this podcast: https://anchor.fm/gruesome-hertzogg/support